Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Diabetes mellitus4971 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A23204 | 23961483 | Indian J Endocrinol Metab | Clinicopathological characteristics and metabolic profiles of non-alcoholic fatty liver disease in Indian patients with normal body mass index: Do they differ from obese or overweight non-alcoholic fatty liver disease? | 2013 | Details |
| A23214 | 23954219 | Gene | Association between resistin +299A/A genotype and nonalcoholic fatty liver disease in Chinese patients with type 2 diabetes mellitus. | 2013 | Details |
| A23216 | 23951244 | PLoS One | Metformin protects rat hepatocytes against bile acid-induced apoptosis. | 2013 | Details |
| A23229 | 23938069 | J Psychosoc Nurs Ment Health Serv | A "glucose eater" drug as a therapeutic agent in psychiatry. | 2013 | Details |
| A23230 | 23935829 | PLoS One | Serum uric acid and non-alcoholic fatty liver disease in non-diabetic Chinese men. | 2013 | Details |
| A23238 | 23932529 | Psychosomatics | Increased risk of chronic liver disease in patients with schizophrenia: a population-based cohort study. | 2013 | Details |
| A23244 | 23929732 | Hepatology | Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes. | 2014 | Details |
| A23252 | 23924495 | Hepatobiliary Pancreat Dis Int | Liver steatosis correlates with iron overload but not with HFE gene mutations in chronic hepatitis C. | 2013 | Details |
| A23257 | 23922564 | Hepat Mon | Non alcoholic fatty liver disease in southern Iran: a population based study. | 2013 | Details |
| A23268 | 23914227 | Hepat Mon | Estimation of diagnosis and treatment costs of non-alcoholic Fatty liver disease: a two-year observation. | 2013 | Details |
| A23274 | 23909257 | Vnitr Lek | [Liver disorders in diabetic patients]. | 2013 | Details |
| A23279 | 23902132 | Metab Syndr Relat Disord | Gender difference in hepatic steatosis index and lipid accumulation product ability to predict incident metabolic syndrome in the historical cohort of the Brisighella Heart Study. | 2013 | Details |
| A23282 | 23899279 | Expert Rev Gastroenterol Hepatol | Interaction of type 2 diabetes and nonalcoholic fatty liver disease. | 2013 | Details |
| A23289 | 23896376 | Biochimie | Ectopic lipid accumulation: A potential cause for metabolic disturbances and a contributor to the alteration of kidney function. | 2013 | Details |
| A23294 | 23891824 | Gene | Peroxisome proliferator-activated receptors alpha and gamma2 polymorphisms in nonalcoholic fatty liver disease: a study in Brazilian patients. | 2013 | Details |
| A23302 | 23884827 | Eur Rev Med Pharmacol Sci | Role of insulin resistance and adipocytokines on serum alanine aminotransferase in obese patients with type 2 diabetes mellitus. | 2013 | Details |
| A23306 | 23879722 | Curr Med Res Opin | Effect of tobacco smoking and smoking cessation on plasma lipoproteins and associated major cardiovascular risk factors: a narrative review. | 2013 | Details |
| A23313 | 23855299 | J Gastroenterol Hepatol | Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches. | 2013 | Details |
| A23317 | 23855290 | J Gastroenterol Hepatol | Epidemiology of alcoholic and nonalcoholic fatty liver disease in China. | 2013 | Details |
| A23356 | 23845075 | Curr Diabetes Rev | The influence of diabetes in the pathogenesis and the clinical course of hepatocellular carcinoma: recent findings and new perspectives. | 2013 | Details |
| A23358 | 23843938 | PLoS One | Liver fat content, evaluated through semi-quantitative ultrasound measurement, is associated with impaired glucose profiles: a community-based study in Chinese. | 2013 | Details |
| A23364 | 23842931 | Acta Cir Bras | Diabetes mellitus triggers oxidative stress in the liver of alloxan-treated rats: a mechanism for diabetic chronic liver disease. | 2013 | Details |
| A23382 | 23830602 | Acad Radiol | MR fat fraction mapping: a simple biomarker for liver steatosis quantification in nonalcoholic fatty liver disease patients. | 2013 | Details |
| A23395 | 23816817 | Trends Mol Med | Interactions among bone, liver, and adipose tissue predisposing to diabesity and fatty liver. | 2013 | Details |
| A23397 | 23815500 | Antioxid Redox Signal | Oxidized fatty acids: A potential pathogenic link between fatty liver and type 2 diabetes in obese adolescents? | 2013 | Details |
| A23423 | 23796801 | Gene | Associations of the PTEN -9C>G polymorphism with insulin sensitivity and central obesity in Chinese. | 2013 | Details |
| A23425 | 23794308 | Turk J Gastroenterol | Relationship between serum aminotransferase levels and metabolic disorders in northern China. | 2012 | Details |
| A23428 | 23792440 | Pol Arch Med Wewn | Relationship between ultrasound features of nonalcoholic fatty liver disease and cardiometabolic risk factors in patients with newly diagnosed type 2 diabetes. | 2013 | Details |
| A23443 | 23776098 | Mol Carcinog | Genetic variation in the PNPLA3 gene and hepatocellular carcinoma in USA: risk and prognosis prediction. | 2013 | Details |
| A23445 | 23775317 | Dig Dis Sci | Predictors of all-cause mortality and liver-related mortality in patients with non-alcoholic fatty liver disease (NAFLD). | 2013 | Details |
| A23447 | 23772273 | World J Diabetes | Gastrointestinal complications of diabetes mellitus. | 2013 | Details |
| A23449 | 23770462 | Mol Cell Endocrinol | Hepatic energy metabolism in human diabetes mellitus, obesity and non-alcoholic fatty liver disease. | 2013 | Details |
| A23459 | 23760677 | Diabetologia | A history of previous gestational diabetes mellitus is associated with adverse changes in insulin secretion and VLDL metabolism independently of increased intrahepatocellular lipid. | 2013 | Details |
| A23474 | 23747246 | Cell Metab | Innate immune receptors: key regulators of metabolic disease progression. | 2013 | Details |
| A23488 | 23737314 | Acta Med Iran | Predictive value of having positive family history of cardiovascular disorders, diabetes mellitus, dyslipidemia, and hypertension in non-alcoholic fatty liver disease patients. | 2013 | Details |
| A23494 | 23730487 | Korean J Fam Med | Non-alcoholic Fatty Liver Disease and Chronic Kidney Disease in Koreans Aged 50 Years or Older. | 2013 | Details |
| A23496 | 23727264 | Gastroenterology | Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease. | 2013 | Details |
| A23502 | 26201794 | Hepatol Int | Fatty liver score and 15-year incidence of type 2 diabetes. | 2013 | Details |
| A23507 | 26201786 | Hepatol Int | Prevalence and risk factors of non-alcoholic fatty liver disease in a multiracial suburban Asian population in Malaysia. | 2012 | Details |
| A23508 | 26201775 | Hepatol Int | Should visceral fat, strictly linked to hepatic steatosis, be depleted to improve survival? | 2012 | Details |
| A23518 | 23716995 | World J Gastroenterol | Nonalcoholic fatty liver disease and microvascular complications in type 2 diabetes. | 2013 | Details |
| A23544 | 23695216 | Am J Physiol Endocrinol Metab | Interferon regulatory factor 7 deficiency prevents diet-induced obesity and insulin resistance. | 2013 | Details |
| A23552 | 23688357 | Cardiovasc Diabetol | Association between non-alcoholic fatty pancreatic disease (NAFPD) and the metabolic syndrome: case-control retrospective study. | 2013 | Details |
| A23559 | 23676586 | Intern Med | Effects of liraglutide, a human glucagon-like peptide-1 analogue, on body weight, body fat area and body fat-related markers in patients with type 2 diabetes mellitus. | 2013 | Details |
| A23562 | 23672077 | Rinsho Byori | [Clinical significance of the measurement of serum cytokeratin-18 in patients with non-alcoholic steatohepatitis]. | 2013 | Details |
| A23565 | 23671610 | PLoS One | The association between nonalcoholic fatty pancreas disease and diabetes. | 2013 | Details |
| A23567 | 23668723 | Proc Nutr Soc | Ectopic fat, insulin resistance and non-alcoholic fatty liver disease. | 2013 | Details |
| A23576 | 23663765 | Zhonghua Gan Zang Bing Za Zhi | [Significance of high sensitivity C-reactive protein level for predicting risk of nonalcoholic fatty liver in type 2 diabetes mellitus patients]. | 2013 | Details |
| A23580 | 23659066 | Klin Med (Mosk) | [Low and very low density lipoproteins: pathogenetic and clinical significance]. | 2013 | Details |
| A23582 | 23657989 | Intern Emerg Med | Physical activity for the prevention and treatment of metabolic disorders. | 2013 | Details |
| A23588 | 23653642 | Int J Endocrinol | Nonalcoholic Fatty liver disease, diabetes mellitus and cardiovascular disease: newer data. | 2013 | Details |
| A23596 | 23647015 | Br J Pharmacol | Quercetin and allopurinol reduce liver thioredoxin-interacting protein to alleviate inflammation and lipid accumulation in diabetic rats. | 2013 | Details |
| A23597 | 23643483 | Toxicol Lett | Interactive effects of smoking and glutathione S-transferase polymorphisms on the development of non-alcoholic fatty liver disease. | 2013 | Details |
| A23604 | 23634670 | Diabetes Technol Ther | Obesity and diabetes: newer concepts in imaging. | 2013 | Details |
| A23609 | 23627940 | Curr Med Chem | Pharmacological inhibition of protein tyrosine phosphatase 1B: a promising strategy for the treatment of obesity and type 2 diabetes mellitus. | 2013 | Details |
| A23613 | 23626730 | PLoS One | Influence of non-alcoholic fatty liver disease on autonomic changes evaluated by the time domain, frequency domain, and symbolic dynamics of heart rate variability. | 2013 | Details |
| A23616 | 23625197 | Curr Diab Rep | The future of thiazolidinedione therapy in the management of type 2 diabetes mellitus. | 2013 | Details |
| A23630 | 23613622 | World J Gastroenterol | Dipeptidyl peptidase-4: a key player in chronic liver disease. | 2013 | Details |
| A23631 | 23612512 | Eur J Clin Nutr | Overweight, obesity and related non-communicable diseases in Asian Indian girls and women. | 2013 | Details |
| A23641 | 23603006 | Food Chem Toxicol | Amelioration by chicory seed extract of diabetes- and oleic acid-induced non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) via modulation of PPARα and SREBP-1. | 2013 | Details |
| A23647 | 23600144 | Yao Xue Xue Bao | [Effects of pomegranate flowers polyphenols on liver PON expression of diabetes combining non-alcoholic fat liver diseases rats]. | 2013 | Details |
| A23652 | 23596966 | Clin Sci (Lond) | Non-alcoholic fatty liver disease is associated with an increased prevalence of atrial fibrillation in hospitalized patients with type 2 diabetes. | 2013 | Details |
| A23666 | 23584921 | High Blood Press Cardiovasc Prev | Non-alcoholic fatty liver disease is not associated with vitamin D deficiency in essential hypertension. | 2013 | Details |
| A23672 | 23578506 | Zhonghua Yi Xue Za Zhi | [Liver disease spectrum in hospitalized type 2 diabetes and related risk factors analysis of non-alcoholic fatty liver disease]. | 2013 | Details |
| A23677 | 23569998 | Asian Pac J Trop Biomed | Elevated alanine aminotransferase activity is not associated with dyslipidemias, but related to insulin resistance and higher disease grades in non-diabetic non-alcoholic fatty liver disease. | 2012 | Details |
| A23684 | 23565851 | Expert Opin Drug Metab Toxicol | Role of microRNAs in the regulation of drug metabolism and disposition genes in diabetes and liver disease. | 2013 | Details |
| A23704 | 23553630 | J Biol Chem | Metabolomic profiling reveals a role for caspase-2 in lipoapoptosis. | 2013 | Details |
| A23707 | 23548687 | Digestion | Clinical characteristics and time trends in etiology of hepatocellular cancer in Germany. | 2013 | Details |
| A23731 | 23528112 | Scand J Urol | Non-alcoholic fatty liver disease is associated with benign prostate hyperplasia in men and with overactive bladder in women. | 2013 | Details |
| A23739 | 23517307 | J Gastroenterol Hepatol | Non-alcoholic fatty liver disease in diabetics--prevalence and predictive factors in a multiracial hospital clinic population in Malaysia. | 2013 | Details |
| A23751 | 23510198 | Diabet Med | Liver enzymes, race, gender and diabetes risk: the Atherosclerosis Risk in Communities (ARIC) Study. | 2013 | Details |
| A23758 | 23507799 | Nat Rev Gastroenterol Hepatol | Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. | 2013 | Details |
| A23763 | 23504926 | Hepatology | Both resistance training and aerobic training reduce hepatic fat content in type 2 diabetic subjects with nonalcoholic fatty liver disease (the RAED2 Randomized Trial). | 2013 | Details |
| A23777 | 23489256 | Hepatol Res | Efficacy and safety in sitagliptin therapy for diabetes complicated by non-alcoholic fatty liver disease. | 2013 | Details |
| A23792 | 23478246 | Minerva Gastroenterol Dietol | Liver steatosis in celiac disease: the open door. | 2013 | Details |
| A23795 | 23477499 | Antioxid Redox Signal | Peroxiredoxin 4 protects against nonalcoholic steatohepatitis and type 2 diabetes in a nongenetic mouse model. | 2013 | Details |
| A23812 | 23453039 | Metabolism | Involvement of regucalcin in lipid metabolism and diabetes. | 2013 | Details |
| A23816 | 23451184 | PLoS One | Non-alcoholic fatty liver disease is associated with an increased incidence of atrial fibrillation in patients with type 2 diabetes. | 2013 | Details |
| A23824 | 26201622 | Hepatol Int | Epidemiology of a fast emerging disease in the Asia-Pacific region: non-alcoholic fatty liver disease. | 2012 | Details |
| A23849 | 23430399 | Med Mol Morphol | A murine model for non-alcoholic steatohepatitis showing evidence of association between diabetes and hepatocellular carcinoma. | 2013 | Details |
| A23867 | 23418085 | Obesity (Silver Spring) | Interactions of allelic variance of PNPLA3 with nongenetic factors in predicting nonalcoholic steatohepatitis and nonhepatic complications of severe obesity. | 2013 | Details |
| A23868 | 23418072 | Obesity (Silver Spring) | A metabolically healthy obese phenotype in hispanic participants in the IRAS family study. | 2013 | Details |
| A23880 | 23406154 | Lipids Health Dis | Effect of Mukitake mushroom (Panellus serotinus) on the pathogenesis of lipid abnormalities in obese, diabetic ob/ob mice. | 2013 | Details |
| A23892 | 23398788 | Arch Med Res | Increased risk of type 2 diabetes in subjects with both elevated liver enzymes and ultrasonographically diagnosed nonalcoholic fatty liver disease: a 4-year longitudinal study. | 2013 | Details |
| A23895 | 23360884 | Br J Nutr | Gut microbiota and metabolic disorders: How prebiotic can work? | 2013 | Details |
| A23912 | 23392740 | Pathologe | [Non-alcoholic steatohepatitis and cirrhosis in young adult patients with hypothalamic-pituitary dysfunction]. | 2013 | Details |
| A23935 | 23374505 | Hepatol Res | Derangement of ghrelin secretion after long-term high-fat diet feeding in rats. | 2013 | Details |
| A23946 | 23363012 | Ann N Y Acad Sci | Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals. | 2013 | Details |
| A23964 | 23347437 | Hepatol Res | Survey of non-B, non-C liver cirrhosis in Japan. | 2013 | Details |
| A23971 | 23337953 | Nat Rev Endocrinol | The role of hepatokines in metabolism. | 2013 | Details |
| A23979 | 23329465 | Drugs | Nonalcoholic fatty liver disease: current issues and novel treatment approaches. | 2013 | Details |
| A23982 | 23329013 | Dig Dis Sci | Fat mass and obesity-associated gene enhances oxidative stress and lipogenesis in nonalcoholic fatty liver disease. | 2013 | Details |
| A23990 | 23320802 | Alcohol Clin Exp Res | Hepatic and extrahepatic malignancies in cirrhosis caused by nonalcoholic steatohepatitis and alcoholic liver disease. | 2013 | Details |
| A23997 | 23317398 | Curr Pharm Des | Ezetimibe therapy for dyslipidemia: an update. | 2013 | Details |
| A24003 | 23312215 | J Diabetes Complications | Prognostic implication of liver histology in patients with nonalcoholic fatty liver disease in diabetes. | 2013 | Details |
| A24019 | 23299577 | Hepatology | Role of vascular endothelial growth factor in the pathophysiology of nonalcoholic steatohepatitis in two rodent models. | 2013 | Details |
| A24020 | 23298957 | Curr Opin Lipidol | Perspective: nonalcoholic fatty liver disease and cardiovascular risk. | 2013 | Details |
| A24029 | 23294790 | J Diabetes Sci Technol | A simple Indian diabetes risk score could help identify nondiabetic individuals at high risk of non-alcoholic fatty liver disease (CURES-117). | 2012 | Details |
| A24032 | 23293330 | J Clin Endocrinol Metab | Clinical Review: Nonalcoholic fatty liver disease: a novel cardiometabolic risk factor for type 2 diabetes and its complications. | 2013 | Details |
| A24037 | 23293196 | Ann Hepatol | Utility of noninvasive methods for the characterization of nonalcoholic liver steatosis in the family practice. The "VARES" Italian multicenter study. | 2013 | Details |